These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14060049)

  • 1. SOME OBSERVATIONS IN RELATION TO PROPERDIN SYSTEM. III. RELATION BETWEEN SERUM PROPERDIN LEVEL AND ANTI-TUBERCULOUS DRUG THERAPY IN HUMAN PULMONARY TUBERCULOSIS.
    MAJUMDAR AC; SEN R; MATHUR PD
    Ann Biochem Exp Med; 1963 Aug; 23():305-8. PubMed ID: 14060049
    [No Abstract]   [Full Text] [Related]  

  • 2. SOME OBSERVATIONS IN RELATION TO THE PROPERDIN SYSTEM. V. COMPARATIVE STUDIES ON SERUM PROTEIN PATTERN OF HUMAN PULMONARY TUBERCULOSIS PATIENTS UNDER CONVENTIONAL ANTI-TUBERCULAR THERAPY.
    MAJUMDAR AC; SEN R; MATHUR PD
    Ann Biochem Exp Med; 1963 Dec; 23():583-8. PubMed ID: 14154203
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the drug resistance of Myc. tuberculosis isolated from patients with primary pulmonary tuberculosis. Bacteriological and clinical observations].
    ZORZOLI P; MONCALVO F
    G Ital Tuberc Mal Torace; 1962; 16():219-passim. PubMed ID: 14003952
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pyrazinamide in association with streptomycin, PAS and isoniazid in the therapy of pulmonary tuberculosis].
    TODOROFF T; FRANZOSI P
    Minerva Med; 1962 Sep; 53():2667-73. PubMed ID: 13985260
    [No Abstract]   [Full Text] [Related]  

  • 5. COMBINED DRUG THERAPY OF PULMONARY TUBERCULOSIS.
    BOESZOERMENYI M; FAUSZT I; KANITZ E; SCHWEIGER O
    Ther Hung; 1963; 12():9-14. PubMed ID: 14059821
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacteriostatic concentration of tubazid, streptomycin and PAS in the blood of tuberculous patients in separate and combined administration of the drugs].
    Bibik NF
    Probl Tuberk; 1969; 47(4):58-62. PubMed ID: 5368447
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver function during tuberculosis therapy with streptomycin, isoniazid and aminosalicylate].
    Aamodt T
    Nord Med; 1970 Jun; 83(24):774. PubMed ID: 5426083
    [No Abstract]   [Full Text] [Related]  

  • 8. [METHOD FOR EVALUATING THE STRENGTH OF SYNTHETIC ANTIBIOTICS IN THE BLOOD SERUM DURING CHEMOTHERAPY OF TUBERCULOSIS].
    OKAMOTO K; FUJINAGA R; YAMAUCHI H
    Kekkaku; 1963 Sep; 38():413-7. PubMed ID: 14056005
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
    Charpin J; Taranger J; Boutin C; Girbal JP
    Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study on an intermittent mode of pulmonary tuberculosis therapy using streptomycin and isoniazid].
    Burzibu JM; Durante C; Ceicu A; el Fassi el Fahri M; Bahsoun H
    Maroc Med; 1974 May; 54(579):307-13. PubMed ID: 4444314
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 14. [Directions for the treatment of children with primary pulmonary and hilar lymph node tuberculosis].
    van ZEBEN ; van der DRIFT
    Maandschr Kindergeneeskd; 1963 Jan; 31():3-25. PubMed ID: 14003349
    [No Abstract]   [Full Text] [Related]  

  • 15. [OUR EXPERIENCE WITH THE TREATMENT OF PULMONARY TUBERCULOSIS RESISTANT TO CLASSICAL TUBERCULOSTATIC DRUGS].
    KOVACEVIC M; MILUTINOVIC R; KONJOVIC M; ZIGIC M
    Tuberkuloza; 1963; 15():250-3. PubMed ID: 14067279
    [No Abstract]   [Full Text] [Related]  

  • 16. [PROPERDIN IN THE BLOOD SERUM OF PATIENTS WITH TUBERCULOSIS DURING THERAPY WITH ANTIBACTERIAL PREPARATIONS AND TUBERCULIN].
    AVERINA EP
    Vopr Med Khim; 1964; 10():46-53. PubMed ID: 14207491
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients.
    MANDEL W; HEATON AD; RUSSELL WF; MIDDLEBROOK G
    J Clin Invest; 1959 Aug; 38(8):1356-65. PubMed ID: 13673092
    [No Abstract]   [Full Text] [Related]  

  • 18. SOME OBSERVATIONS IN RELATION TO PROPERDIN SYSTEM. IV. RELATION OF SERUM COMPLEMENT ACTIVITY AND PROPERDIN LEVEL OF NORMAL ALBINO RATS TO STREPTOMYCIN THERAPY AND DIET.
    SEN R; MATHUR PD; MAJUMDAR AC
    Ann Biochem Exp Med; 1963 Dec; 23():577-82. PubMed ID: 14154202
    [No Abstract]   [Full Text] [Related]  

  • 19. [PROPERDIN IN THE BLOOD OF PATIENTS WITH TUBERCULOSIS OF THE LUNGS].
    AVERINA EP; BORKHOVETSKAIA AA
    Lab Delo; 1964; 10():276-8. PubMed ID: 14138478
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute fulminant hepatic failure with bilateral tuberculous cavitation.
    Bruno MS; Ober WB
    N Y State J Med; 1968 Nov; 68(22):2934-40. PubMed ID: 5247023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.